SCHEMBL5360079

SCHEMBL5360079

Cc1sc(NC(C)C(N)=O)nc1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 2/20 0.64
ALOX5 P09917 1/20 0.58
GSTO1 P78417 1/20 0.55
ALDH1A1 P00352 5/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
MAPK1 P28482 1/20 0.53
MAOA P21397 7/20 0.52
MAOB P27338 7/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
MAPT P10636 3/20 0.52
RAB9A P51151 3/20 0.52
LMNA P02545 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
PKM P14618 1/20 0.52
NPC1 O15118 2/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18215318 0.80 ALOX5 (0.72) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL4459460 0.77 ALOX5 (0.56) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL4459465 0.77 ALOX5 (0.56) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL10810440 0.77 ALOX5 (0.76) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL23604932 0.76 XIAP (0.68) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL15086878 0.76 ALOX5 (0.74) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL4459618 0.75 ALOX5 (0.54) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL4459625 0.75 ALOX5 (0.54) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL5360082 0.75 ALOX5 (0.56) XIAPALOX5GSTO1ALDH1A1HSD17B10
SCHEMBL25327043 0.75 MAOA (0.60) XIAPALOX5GSTO1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7307095-B2 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide IRM LLC (BM) 2007-12-11 US disclosed